While none of the proteins had already been approved drugs or drugs in clinical trials, recombinant human G-CSF (rhG-CSF), such as filgrastim and lenograstim, is used to treat the neutropenia caused by chemotherapy to stimulate the production of granulocytes from the bone marrow57. The gene discussed is CSF3; the disease is neutropenia.